Basic Info:
CAS No.: 73-78-9
EINECS No: 200-803-8
Molecular Formula: C14H23ClN2O
Molecular Weight: 270.8
Assay: 99.5%
Melting Point: 80-82°C
Appearance: White crystalline powder
Lidocaine HCL Usage:
Topical lidocaine has been shown in some patients to relieve the pain of postherpetic neuralgia (a
complication of shingles), though there is not enough study evidence to recommend it as a first-line
treatment. IV lidocaine also has uses as a temporary fix for tinnitus. Although not completely curing
the disorder, it has been shown to reduce the effects by around two thirds.
Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated
in the acute management of ventricular arrhythmias such as those occurring in relation to acute
myocardial infarction, or during cardiac manipulation, such as cardiac surgery.
Lidocaine HCL COA:
CAS No.: 73-78-9
EINECS No: 200-803-8
Molecular Formula: C14H23ClN2O
Molecular Weight: 270.8
Assay: 99.5%
Melting Point: 80-82°C
Appearance: White crystalline powder
Lidocaine HCL Usage:
Topical lidocaine has been shown in some patients to relieve the pain of postherpetic neuralgia (a
complication of shingles), though there is not enough study evidence to recommend it as a first-line
treatment. IV lidocaine also has uses as a temporary fix for tinnitus. Although not completely curing
the disorder, it has been shown to reduce the effects by around two thirds.
Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated
in the acute management of ventricular arrhythmias such as those occurring in relation to acute
myocardial infarction, or during cardiac manipulation, such as cardiac surgery.
| Related Products | |
| Benzocaine | 94-09-7 |
| Benzocaine HCI | 73-78-9 |
| Lidocaine | 137-58-6 |
| Lidocaine HCI | 73-78-9 |
| Procaine | 59-46-1 |
| Procaine HCI | 51-05-8 |
| Prilocaine | 721-50-6 |
| Prilocaine HCI | 1786-81-8 |
| Tetracaine | 94-24-6 |
| Tetracaine HCI | 136-47-0 |
| Bupivacaine | 2180-92-9 |
| Bupivacaine HCI | 14252-80-3 |
| Levobupivacaine Hydrochloride | 27262-48-2 |
| Pramoxine HCI | 637-58-1 |
| Proparacaine HCI | 5875/6/9 |
| Articaine HCI | 23964-57-0 |
| Mepivacaine HCl | 1722-62-9 |
| Larocaine | 94-15-5 |
| Ropivacaine HCI | 132112-35-7/98717-15-8 |
| Dibucaine HCI | 637-58-1 |
Lidocaine HCL COA:
| Item | Standard | Result |
| Characteristics | White or almost white crystalline powder | Conform |
| Identification | Should meet related requirements | Conform |
| Appearance of solution | Should meet related requirements | Passed |
| PH | 3.5-5.5 | 4.5 |
| Specific optical rotation | +135°~+150° | +143° |
| Boiling point | 350.8°C at 760 mmHg | Conform |
| Flash point | 166°C | Conform |
| Lincomycin B | 5.0% max | 2.9% |
| Heavy metals | 5ppm max | Conform |
| Residue on ignition | 0.5% max | 0.1% |
| Water | 3.1-4.6% | 4.3% |
| Bacterial endotoxins | smaller than 0.5IU/mg | smaller than0.5IU/mg |
| Assay | 89.5%~102.0% of lincomycin | 99.5% |